24/7 Cell & Gene Control Tower Provides Agile Solution For Critical Shipments

Marken’s Cell and Gene Control Tower re-routed six critical shipments of CAR-T drug products from Amsterdam to the UK and Spain, overcoming scheduling conflicts and logistical obstacles caused by the airline carrier and regional regulatory hurdles. The shipments arrived ahead of time and within specifications, valued at an estimated $380K, allowing non-Hodgkin’s lymphoma patients to receive their commercial CAR-T drug product.